Cargando…
The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
Although the CD90 (Thy-1) was proposed as biomarker of several tumors and cancer stem cells, the involvement of this molecule in the progression of hepatocellular carcinoma (HCC) and other less frequent hepatic neoplasms is still undefined. The distribution of CD90 was investigated both in in vivo (...
Autores principales: | Sukowati, Caecilia Hapsari Ceriapuri, Anfuso, Beatrice, Torre, Giuliano, Francalanci, Paola, Crocè, Lory Saveria, Tiribelli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792890/ https://www.ncbi.nlm.nih.gov/pubmed/24116172 http://dx.doi.org/10.1371/journal.pone.0076830 |
Ejemplares similares
-
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2015) -
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
por: Sukowati, Caecilia HC, et al.
Publicado: (2012) -
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
por: Pascut, Devis, et al.
Publicado: (2019) -
The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations
por: Luong, An B., et al.
Publicado: (2020) -
PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma
por: Sukowati, Caecilia, et al.
Publicado: (2023)